CN111018725B - Preparation method of (1R, 3S) -3-aminocyclopentanol chiral acid salt - Google Patents
Preparation method of (1R, 3S) -3-aminocyclopentanol chiral acid salt Download PDFInfo
- Publication number
- CN111018725B CN111018725B CN201811171816.5A CN201811171816A CN111018725B CN 111018725 B CN111018725 B CN 111018725B CN 201811171816 A CN201811171816 A CN 201811171816A CN 111018725 B CN111018725 B CN 111018725B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- aminocyclopentanol
- acid
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses a preparation method of (1R, 3S) -3-aminocyclopentanol chiral acid salt, which is a compound shown in a formula I, and comprises the following steps of e, d-e, c-d-e, b-c-d-e or a-b-c-d-e in a synthetic route:
wherein R is 1 Is C1-C4 alkyl, R is phenyl, substituted phenyl, benzylAny one of them. The invention takes the easily obtained compound (R-mandelic acid) as the raw material, the purity of the corresponding body of the finally prepared (1R, 3S) -3-aminocyclopentanol chiral acid salt can reach 99.9 percent, the optical purity is high, the industrial production of the (1R, 3S) -3-aminocyclopentanol chiral acid salt with a single configuration is easy to realize, and the invention has remarkable progress compared with the prior art.
Description
Technical Field
The invention relates to a preparation method of (1R, 3S) -3-aminocyclopentanol chiral acid salt, and belongs to the technical field of pharmaceutical chemistry.
Background
Bictagravir is an innovative once-a-day integrase chain transfer inhibitor (INSTI) currently in phase 3 clinical trials as part of a single-tablet regimen for use in combination with FTC/TAF in the treatment of HIV infection. Gilead Sciences published data from a phase 2 clinical study, evaluating efficacy, safety and tolerability of the combination of bictagvir (BIC, 75 mg) and emtricitabine/tenofovir (200 mg/25mg, FTC/TAF) against primary adult patients with HIV-1 infection. Meanwhile, the combination of dolutegradvir (50 mg) (DTG) and emtricitabine/tenofovir alafenamide (200 mg/25 mg) (FTC/TAF) was compared. The results of the study found that both protocols exhibited high virologic response rates at both week 24 and week 48. The specific chemical structural formula of the Bictegravir is shown below:
in patent WO2014100323, the following two synthetic routes for the compound bictagravir are reported:
route one:
route two:
from the above synthetic route, it can be seen that: the chiral center in the Bictegravir structure is introduced by the key intermediate (1R, 3S) -3-aminocyclopentanol
Thus, the chiral purity of (1R, 3S) -3-aminocyclopentanol determines the purity of the following synthetic intermediates, thus playing a crucial role in synthesizing high purity Bictegravir.
World patent WO2015195656 discloses
A method for synthesizing (1R, 3S) -3-aminocyclopentanol as a raw material, but the purity of the (1R, 3S) -3-aminocyclopentanol prepared by the method disclosed in the patent is lower, and the content of isomers is higher.
Chinese patent No. cn201210090148.X discloses a method for synthesizing cis-3-amino-cyclopentanol hydrochloride from hydroxylamine hydrochloride and benzyloxycarbonyl chloride as starting materials, and although the purity GC content of the cis-3-amino-cyclopentanol hydrochloride of the patent reaches 98%, the total yield reaches 36.5%, the synthesis method has no chiral control, and the obtained product is 1: the cis-mixture of (1R, 3S) -3-aminocyclopentanol and (1S, 3S) -3-aminocyclopentanol of configuration 1, has no resolution of the isomers and has a lower optical purity and overall yield if the purity and overall yield are calculated as (1R, 3S) -3-aminocyclopentanol hydrochloride of single optical purity after resolution.
Disclosure of Invention
Aiming at the problems in the prior art, the invention aims to provide a preparation method of (1R, 3S) -3-aminocyclopentanol chiral acid salt with high optical purity and high yield so as to meet the industrial production requirements of (1R, 3S) -3-aminocyclopentanol and Bictegravir.
In order to achieve the above purpose, the invention adopts the following technical scheme:
a preparation method of (1R, 3S) -3-aminocyclopentanol chiral acid salt, wherein the (1R, 3S) -3-aminocyclopentanol chiral acid salt is a compound shown in a formula I, and comprises the following steps of e, d-e, c-d-e, b-c-d-e or a-b-c-d-e in a synthetic route:
wherein R is 1 C1-C4 alkyl (preferably ethyl), R is any one of phenyl, substituted phenyl and benzyl.
Preferably, step a is carried out by reacting a compound of formula VI with R 1 And (3) carrying out an esterification reaction on OH to obtain a compound of the formula V.
As a further preferred embodiment, the reaction of step a is under the action of sulfuric acid.
Preferably, the step b is a hydroxylation reaction of the compound of formula V with a hydroxylation reagent, more preferably hydroxylamine hydrochloride, to obtain the compound of formula IV.
As a further preferred embodiment, in step b, the molar ratio of hydroxylamine reagent to compound of formula V is from 1.5:1 to 3:1.
Preferably, the step c is to react the compound of formula IV with cyclopentadiene under the catalysis of sodium periodate to obtain the compound of formula III.
As a further preferred embodiment, in step c, the molar ratio of cyclopentadiene to the compound of formula IV is from 1.5:1 to 3:1.
As a further preferred embodiment, in step c, the molar ratio of sodium periodate to the compound of formula IV is from 0.8:1 to 2:1.
As a further preferable scheme, the step c is to react the compound of the formula IV with cyclopentadiene in a mixed solvent of water and an alcohol solvent under the catalysis of sodium periodate to obtain the compound of the formula III, wherein the alcohol solvent is at least one selected from methanol, ethanol, n-propanol and n-butanol.
As a further preferred scheme, the specific operation of the step c is as follows: dropwise adding an alcohol solution of the compound of the formula IV into a mixed solvent of water and an alcohol solvent containing sodium periodate and cyclopentadiene, and then reacting for 12-20 hours at 15-30 ℃ to obtain the compound of the formula III; the volume ratio of water to the alcohol solvent in the mixed solvent is preferably 1:1-1:3.
Preferably, the step d is to perform hydrogen catalytic reduction reaction on the compound of the formula III to obtain the compound of the formula II; the catalyst used in the reaction is preferably a palladium-carbon catalyst, a platinum catalyst or a nickel catalyst, and more preferably a palladium-carbon catalyst; the solvent used in the reaction is preferably an alcohol solvent selected from at least one of methanol, ethanol, n-propanol, n-butanol, isopropanol, t-butanol, and ethylene glycol.
As a further preferred embodiment, in step d, the catalyst is used in an amount of from 2 to 15% by weight of the compound of formula III.
As a further preferable scheme, the specific operation of the step d is as follows: adding a compound of formula III, a catalytic reduction catalyst and an alcohol solvent into a high-pressure reaction kettle, and carrying out reduction reaction for 8-12 hours at 50-60 ℃ in a hydrogen atmosphere to obtain the compound of formula II.
As a preferable scheme, the step e is to react a compound of the formula II with strong alkali first and then with chiral acid to obtain the compound of the formula I; the strong alkali is preferably at least one of potassium hydroxide, sodium hydroxide, lithium hydroxide, sodium methoxide, sodium ethoxide, potassium methoxide and potassium ethoxide, and is further preferably potassium hydroxide or sodium hydroxide; the chiral acid is preferably any one of D-tartaric acid, D-malic acid, D-camphorsulfonic acid, D-di-p-toluoyl tartaric acid and D-mandelic acid.
As a further preferred embodiment, in step e, the molar ratio of chiral acid to compound of formula II is from 1:0.5 to 1:1.5.
As a further preferred embodiment, the compound of formula II is reacted with a strong base in an alcoholic solvent at a temperature of from 90 to 130 ℃; the obtained product reacts with chiral acid in alcohol solvent; the alcohol solvent is at least one selected from methanol, ethanol, n-propanol, n-butanol, isopropanol, tertiary butanol and ethylene glycol.
As a further preferable scheme, the step e specifically comprises the following steps: dissolving a compound of the formula II in an alcohol solvent, adding strong alkali, stirring and reacting for 10-25 hours at 90-130 ℃, cooling the reaction liquid to 10-30 ℃, filtering, adding chiral acid into the mother liquid, and stirring and reacting for 1-3 hours at 50-60 ℃ to obtain the compound of the formula I.
Compared with the prior art, the invention has the following remarkable beneficial effects:
the invention takes the easily obtained compound (R-mandelic acid) in the formula VI as the raw material, the required (1R, 3S) -3-aminocyclopentanol chiral acid salt can be prepared through simple four-step reaction, each step of reaction in the whole route has the advantages of simple operation, low production cost, mild reaction condition, easy separation and purification of the product (without purification or crystallization purification), high reaction yield (the lowest molar yield is higher than 78%), easy mass production, the purity of the finally prepared (1R, 3S) -3-aminocyclopentanol chiral acid salt corresponding body can reach 99.9%, the optical purity is high, and the industrial production of the (1R, 3S) -3-aminocyclopentanol chiral acid salt in a single configuration is easy to realize, thereby having remarkable progress compared with the prior art.
Detailed Description
The technical scheme of the invention is further and fully described in the following by combining examples.
Example 1:
when R is 1 Ethyl, R is phenyl, formulaPreparation of the V Compound:
100g of the compound of formula VI (R-mandelic acid) was dissolved in 350ml of ethanol, 28.4g of concentrated sulfuric acid was added at room temperature, the reaction was then refluxed for 5 hours, the reaction was ended, and the temperature was lowered to room temperature, and the obtained esterified liquid (containing the compound of formula V) was directly used for the next reaction.
Example 2:
preparation of the compound of formula IV:
adding 91.4g of hydroxylamine hydrochloride into 550ml of methanol to obtain a solution 1 for later use; adding 120g of potassium hydroxide into 300ml of ethanol to obtain a solution 2 for later use; mixing the solution 1 with the solution 2 below 10 ℃, dropwise adding the esterified solution (containing the compound of the formula V) prepared in the example 1, reacting for 2 hours at 15-25 ℃ after the completion of the dropwise adding, ending the reaction, adjusting the pH of the reaction solution to 7.0-7.5, concentrating, and recrystallizing the concentrate with ethyl acetate at room temperature to obtain the compound of the formula IV (89 g, molar yield 81%).
Example 3:
preparation of a compound of formula III:
129g of sodium periodate is dissolved in 300ml of water and 600ml of methanol mixed solvent, 79.4g of cyclopentadiene is added, the mixture is stirred uniformly, a methanol solution of a compound of formula IV (100 g of the compound of formula IV is dissolved in 400ml of methanol) is added dropwise, after the dropwise addition is finished, the mixture is reacted at 15-25 ℃ for 15-18 hours, the reaction is ended, filtration and concentration are carried out, 50ml of methanol and 500ml of water mixed solvent are added into the concentrated mother solution, stirring and filtration are carried out, 100ml of dichloromethane is added into a filter cake, reflux stirring is carried out for 1 hour, 600ml of methyl tertiary ether solution is added dropwise, precipitated crystals are collected, and the obtained product is dried, thus obtaining the compound of formula III (118.7 g, molar yield is 86.1%, and isomer is less than 0.50%).
Example 4:
preparation of the compound of formula I ((1R, 3S) -3-aminocyclopentanol tartrate) when the chiral acid is D-tartaric acid:
adding 100g of a compound of the formula III, 5g of a palladium-carbon catalyst and 50ml of methanol into a high-pressure reaction kettle, pressing in hydrogen after argon-hydrogen replacement, reacting for 10-12 hours at 50-60 ℃ under the pressure of 2-3 MPa, ending the reaction, filtering, and concentrating the filtrate to obtain a compound of the formula II, wherein the product is directly used for the next reaction without purification;
dissolving a compound shown in a formula II in 1000ml of n-butanol, adding 72.7g of potassium hydroxide solid, reacting for 15-20 hours at 115-120 ℃, ending the reaction, cooling the reaction liquid to 15-20 ℃, filtering, adding 77.9g of D-tartaric acid into the mother liquid, stirring and reacting for 1-2 hours at 50-60 ℃, ending the reaction, cooling the reaction liquid to 15-20 ℃, stirring for 1 hour, filtering, and drying a filter cake to obtain the compound shown in the formula I ((1R, 3S) -3-aminocyclopentanol tartrate, 94.5g, total molar yield of two steps of 87%, and enantiomer of less than 0.1%).
Example 5:
preparation of the compound of formula I ((1R, 3S) -3-aminocyclopentanol camphorsulfonate) when the chiral acid is D-camphorsulfonic acid:
adding 100g of a compound of the formula III, 5g of a nickel catalyst and 50ml of ethanol into an autoclave, pressing in hydrogen after argon-hydrogen substitution, reacting for 10-12 hours at 50-60 ℃ under the autoclave pressure of 2-3 MPa, ending the reaction, filtering, and concentrating the filtrate to obtain the compound of the formula II, wherein the product is directly used for the next reaction without purification;
dissolving a compound shown in a formula II in 1200ml of isopropanol, adding 770.2g of sodium methoxide solid, reacting for 15-20 hours at 115-120 ℃, ending the reaction, cooling the reaction liquid to 15-20 ℃, filtering, adding 120.6g of D-camphorsulfonic acid into a mother liquid (namely the intermediate 3-aminocyclopentanol), stirring and reacting for 1-2 hours at 50-60 ℃, ending the reaction, cooling the reaction liquid to 15-20 ℃, stirring for 1 hour, filtering, and drying a filter cake to obtain the compound shown in the formula I ((1R, 3S) -3-aminocyclopentanol camphorsulfonate, 114.6g, total two-step molar yield of 78.3%, and enantiomer of less than 0.1%).
Example 6:
when the chiral acid is D-malic acid, preparation of a compound of formula I ((1R, 3S) -3-aminocyclopentanol malate):
adding 100g of a compound of the formula III, 5g of a platinum catalyst and 50ml of n-butanol into a high-pressure reaction kettle, pressing in hydrogen after argon-hydrogen replacement, reacting at 50-60 ℃ for 12-14 hours under the high-pressure kettle pressure of 2-3 MPa, ending the reaction, filtering, and concentrating the filtrate to obtain a compound of the formula II, wherein the product is directly used for the next reaction without purification;
dissolving a compound shown in a formula II in 1300ml of methanol, adding 31.1g of lithium hydroxide solid, reacting for 15-20 hours at 115-120 ℃, ending the reaction, cooling the reaction liquid to 15-20 ℃, filtering, adding 69.6g of D-malic acid into the mother liquid, stirring at 50-60 ℃ for reacting for 1-2 hours, ending the reaction, cooling the reaction liquid to 15-20 ℃, stirring for 1 hour, filtering, and drying a filter cake to obtain the compound shown in the formula I ((1R, 3S) -3-aminocyclopentanol malate, 84.2g, total molar yield of two steps of 83.2%, and enantiomer of less than 0.1%).
Comparative example:
the cis-3-amino-cyclopentanol is prepared by the method in patent CN201210090148.X, and resolved by tartaric acid for 4 times to obtain (1R, 3S) -3-amino-cyclopentanol tartrate with ee value of 96%, resolution yield of 30% and total yield of 14.25%.
From the above examples and comparative examples, the chiral purity and yield of the (1R, 3S) -3-aminocyclopentanol chiral acid salt with a single configuration prepared by the preparation method of the invention are far higher than those of the method disclosed in the patent CN201210090148.X, so that the industrial production of the (1R, 3S) -3-aminocyclopentanol chiral acid salt with a single configuration is easier to realize, and the preparation method has remarkable progress.
Finally, it is pointed out here that: the above is only a part of the preferred embodiments of the present invention and should not be construed as limiting the scope of the present invention, and some insubstantial modifications and adaptations of the present invention based on the foregoing are within the scope of the present invention.
Claims (8)
1. A preparation method of (1R, 3S) -3-aminocyclopentanol chiral acid salt, which is a compound of formula I, and is characterized by comprising the following steps a-b-c-d-e in the synthetic route:
wherein R is 1 Is C1-C4 alkyl, R is phenyl or substituted phenyl;
the step d is to make the compound of formula III undergo the process of reduction reaction for 8-12 hr under the condition of 2-3 MPa pressure and 50-60 deg.C in the atmosphere of palladium-carbon catalyst, alcohol solvent and hydrogen gas so as to obtain the compound of formula II.
2. The method of manufacturing according to claim 1, characterized in that: said step a is carried out by reacting a compound of formula VI with R 1 And (3) carrying out an esterification reaction on OH to obtain a compound of the formula V.
3. The method of manufacturing according to claim 1, characterized in that: and the step b is to carry out hydroxylation reaction on the compound of the formula V and a hydroxylation reagent to obtain the compound of the formula IV.
4. A method of preparation according to claim 3, characterized in that: the hydroxylamine reagent is hydroxylamine hydrochloride.
5. The method of manufacturing according to claim 1, characterized in that: the step c is to react a compound shown in the formula IV with cyclopentadiene under the catalysis of sodium periodate to obtain a compound shown in the formula III.
6. The method of manufacturing according to claim 1, characterized in that: the step e is to react the compound of the formula II with strong alkali and then with chiral acid to obtain the compound of the formula I.
7. The method of manufacturing according to claim 6, wherein: the strong alkali is at least one of potassium hydroxide, sodium hydroxide, lithium hydroxide, sodium methoxide, sodium ethoxide, potassium methoxide and potassium ethoxide.
8. The method of manufacturing according to claim 6, wherein: the chiral acid is any one of D-tartaric acid, D-malic acid, D-camphorsulfonic acid, D-di-p-toluoyl tartaric acid and D-mandelic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811171816.5A CN111018725B (en) | 2018-10-09 | 2018-10-09 | Preparation method of (1R, 3S) -3-aminocyclopentanol chiral acid salt |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811171816.5A CN111018725B (en) | 2018-10-09 | 2018-10-09 | Preparation method of (1R, 3S) -3-aminocyclopentanol chiral acid salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111018725A CN111018725A (en) | 2020-04-17 |
| CN111018725B true CN111018725B (en) | 2023-07-07 |
Family
ID=70190781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811171816.5A Active CN111018725B (en) | 2018-10-09 | 2018-10-09 | Preparation method of (1R, 3S) -3-aminocyclopentanol chiral acid salt |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111018725B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102633657A (en) * | 2012-03-30 | 2012-08-15 | 兰州中泰和生物科技有限公司 | Preparation method of cis-3-amino-cyclopentanol hydrochloride |
| CN103923055A (en) * | 2014-04-02 | 2014-07-16 | 黄河三角洲京博化工研究院有限公司 | preparation method of (1S,2R,3S,4R)-2,3-O-isopropylidene-4-aminocyclopentyl-1,2,3-triol |
| CN106470975A (en) * | 2014-06-20 | 2017-03-01 | 吉利德科学公司 | The synthesis of polycyclic carbamoylpyridone compound |
-
2018
- 2018-10-09 CN CN201811171816.5A patent/CN111018725B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102633657A (en) * | 2012-03-30 | 2012-08-15 | 兰州中泰和生物科技有限公司 | Preparation method of cis-3-amino-cyclopentanol hydrochloride |
| CN103923055A (en) * | 2014-04-02 | 2014-07-16 | 黄河三角洲京博化工研究院有限公司 | preparation method of (1S,2R,3S,4R)-2,3-O-isopropylidene-4-aminocyclopentyl-1,2,3-triol |
| CN106470975A (en) * | 2014-06-20 | 2017-03-01 | 吉利德科学公司 | The synthesis of polycyclic carbamoylpyridone compound |
Non-Patent Citations (1)
| Title |
|---|
| Copper-Catalyzed Aerobic Oxidation of N-Substituted Hydroxylamines: Efficient and Practical Access to Nitroso Compounds;Charles P.Frazier等;《Org.Lett.》;20120711;第14卷(第14期);第3620-3623页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111018725A (en) | 2020-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103274968B (en) | Method for producing amantadine compound | |
| CN110590635A (en) | Preparation method of levetiracetam and intermediate thereof | |
| CN112079848A (en) | Synthesis method of baroxavir key intermediate | |
| CN104356012B (en) | The preparation method of sarpogrelate hydrochloride light degradation impurity | |
| US8912345B2 (en) | Method for preparing optically pure (−)-clausenamide compound | |
| CN111018725B (en) | Preparation method of (1R, 3S) -3-aminocyclopentanol chiral acid salt | |
| CN111533746A (en) | Synthesis method of tofacitinib citrate | |
| CN114478290A (en) | Synthetic method of oseltamivir intermediate | |
| CN102603595A (en) | Preparation method of (S)-oxiracetam | |
| CN102603594A (en) | Preparation method of (S)-oxiracetam | |
| CN111961077A (en) | Preparation method of beta sodium glycerophosphate containing crystal water | |
| CN111302996A (en) | Preparation method of high-chiral-purity chloromalastine fumarate | |
| CN107793320B (en) | Method for preparing single-configuration 3-amino-1-butanol by chiral resolution | |
| CN110903230B (en) | Industrial preparation method of pramipentane sulfate | |
| CN112094241B (en) | Preparation method of 1, 4-diazaspiro [5,5] undecane-3-ketone | |
| CN111217709A (en) | Preparation method of (1-fluorocyclopropyl) methylamine hydrochloride | |
| CN106632347B (en) | Preparation method of pyrrolopyrazine compound and salt thereof | |
| CN111848496B (en) | Preparation method of tofacitinib intermediate amine and double hydrochloride thereof | |
| CN103288813A (en) | Preparation method of aprepitant | |
| CN110183355B (en) | Refining method of high-purity o-chloro mandelonitrile | |
| CN115785057B (en) | Preparation method of ticagrelor intermediate compound and salt thereof | |
| CN118026867B (en) | Method for preparing 2- (1R, 5S, 6S) -6- (aminomethyl) -3-ethylbicyclo [3.2.0] heptane-3-alkene-6-acetic acid | |
| CN110964013B (en) | Preparation method of linagliptin and intermediate thereof | |
| CN115960036A (en) | Preparation method of (R) -3-aminopiperidine dihydrochloride | |
| KR20150095970A (en) | Improved process for preparing Oseltamivir |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |